Los Angeles Business Journal
Teledyne Technologies (TDY) agreed to acquire Varex Imaging (VREX) for $1.1B, or $18.90 per share in cash. The deal is expected to close in 2027. Varex's X-ray imaging tech complements Teledyne's portfolio, according to Varex's CEO. Teledyne has previously acquired firms in the healthcare sector, including Dalsa Corp. and DD-Scientific.
How this was made
The 30-second read
Why it matters
The acquisition expands Teledyne's X‑ray product line, potentially increasing revenue streams from oncology imaging.
Market read
The $1.1 billion deal is material for both companies and may trigger price movements in the healthcare equipment sector.
What to watch
Potential regulatory review and cultural integration challenges between the two firms.
Background
Teledyne has a history of acquiring imaging and sensor companies to broaden its healthcare portfolio.
Ticker impact
Teledyne Technologies announced a $1.1 billion all‑cash acquisition of Varex Imaging at $18.90 per share.
TDY may rise 3‑5% on deal news, VREX could see a premium‑linked rally.
Deal size is material for a mid‑cap, cash‑rich acquirer; market typically rewards strategic acquisitions.
Varex Imaging agreed to be acquired by Teledyne Technologies for $18.90 per share in cash.
VREX expected to trade at or slightly above $18.90 until close.
All‑cash offer at a clear premium creates immediate upside for VREX shareholders.
Market effects
Strengthens Teledyne's position in medical imaging and X‑ray detector market.
U.S. healthcare equipment sector may see modest uplift.
Adds to broader trend of consolidation in medical imaging technology.
Counterpoint
Deal financing could strain cash flow; integration risk may offset upside.
Key entities
- ExecutiveSunny Sanyal
President, director and chief executive of Varex Imaging.
